Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1995-3-24
pubmed:abstractText
Integrin receptors localize to focal contact sites and interact with the cytoskeleton via the beta 1 cytoplasmic domain. To study the role of this domain in adhesion, we have expressed in NIH 3T3 cells a cDNA consisting of the interleukin 2 receptor alpha subunit extracellular and transmembrane domains, connected to the integrin beta 1 cytoplasmic domain (IL2R-beta 1). Since the extracellular domain of the chimeric protein has no role in adhesion, this protein could uncouple adhesion from intracellular events. As expected, in a cell line expressing IL2R-beta 1, this chimera was directed to focal contact sites. Unexpectedly, the cells exhibited normal adhesion to fibronectin (FN). However, when a rapid reorganization of the cytoskeleton was induced using lysophosphatidic acid (LPA), IL2R-beta 1 cells detached from FN in contrast to wild-type cells. The detachment in response to LPA could be prevented with cytochalasin D, an inhibitor of actin polymerization. These results imply that a beta 1 cytoplasmic domain, which is uncoupled from adhesion, can compete with the cytoplasmic domain of native integrin beta 1 for cytoskeletal proteins. As a consequence, the IL2R-beta 1 protein acts as a dominant negative effector of adhesion by disrupting the integrin-cytoskeleton connection.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-1283166, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-1373145, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-1376731, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-1643657, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-1845795, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2078570, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2104857, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2116421, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2357375, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2373690, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2454933, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2458362, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2551506, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2788168, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2924798, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-2938015, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-3058164, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-3131349, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-3487386, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-3884631, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-3921554, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-4361679, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-5432063, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-6286831, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-7515874, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-7518428, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-7690620, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-8063864, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-8276865, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-8276872, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-8314789, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-8314843, http://linkedlifedata.com/resource/pubmed/commentcorrection/7532472-8365468
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1059-1524
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1215-23
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1994
pubmed:articleTitle
Integrin beta 1 cytoplasmic domain dominant negative effects revealed by lysophosphatidic acid treatment.
pubmed:affiliation
Department of Pathology, College of Physicians and Surgeons, Columbia University, New York, New York 10032.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't